2-BDCK

2-Bromodeschloroketamine(other names: 2-BDCK, 2-Br-2′-Oxo-PCM, Bromoketamine) is a dissociative substance of the arylcyclohexylamine class, a designer analog of ketamine with a similar chemical structure and effects.

Chemistry
2-Bromodeschloroketamine (2-BDCK) is the homologue of ketamine and deschloroketamine, the brominated version.

Pharmacology
This substance is a relatively new design, the toxicological and pharmacological properties of which are not fully understood and few data are available. It is intended in research studies as a comparison compound to study the metabolism of ketamine.
Trials in rats found that 2-BDCK can produce sedative, stimulant, dissociative and anesthetic effects similar to ketamine.

Legal status
Canada: controlled substance, Schedule I
Germany: controlled substance, NpSG , industrial and scientific use only
UK: class B controlled substance

Technical Information:

Product Name: 2-BDCK
Other Name(s):  2-Bromodeschloroketamine, 2-Br-2′-Oxo-PCM, Bromoketamine
IUPAC Name: 2-(2-bromophenyl)-2-(methylamino)cyclohexan-1-one
CAS: 120807-70-7
Molar Mass: 282.18 g/mol
Molecular Formula: C13H16BrNO
InChi Code: InChI=1S/C13H16BrNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3
InChIKey: XPMMBFIMXKSQIQ-UHFFFAOYSA-N
Canonical SMILES: CNC1(CCCCC1=O)C2=CC=CC=C2Br
Formulation: A crystalline solid